Naringin inhibits chemokine production in an LPS‑induced RAW 264.7 macrophage cell line

Liu,Ying; Su,Wei-Wei; Wang,Sheng; Li,Pei-Bo

doi:10.3892/mmr.2012.1072

December 2012 Volume 6 Issue 6

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

December 2012 Volume 6 Issue 6

Full Size Image

Article

Naringin inhibits chemokine production in an LPS‑induced RAW 264.7 macrophage cell line

Authors:
- Ying Liu
- Wei-Wei Su
- Sheng Wang
- Pei-Bo Li
View Affiliations / Copyright

Affiliations: Key Laboratory of Gene Engineering of the Ministry of Education and Guangdong Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-sen University, Guangzhou, Guangdong 510275, P.R. China
Pages: 1343-1350
|
Published online on: September 10, 2012

https://doi.org/10.3892/mmr.2012.1072
Expand metrics +

Abstract

Naringin has been reported to act as an effective anti-inflammatory compound. In a previous study, we demonstrated that the anti-inflammatory effect of naringin on lipopolysaccharide (LPS)-induced acute lung injury in mice correlated with the inhibition of the nuclear factor-κB (NF-κB) pathway. However, the effects and mechanism of action of naringin on LPS-induced chemokine expression are not yet fully understood. This study aimed to evaluate the effect of naringin on chemokine expression in LPS-induced RAW 264.7 macrophages and to provide insights into the possible underlying mechanisms. We found that the in vitro pre-treatment with naringin led to a significant attenuation in the LPS-induced secretion of interleukin-8 (IL-8), monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1α (MIP-1α). RT-qPCR demonstrated that naringin significantly reduced the LPS-induced upregulation of IL-8, MCP-1 and MIP-1α mRNA expression in a dose-dependent manner. Additionally, western blot analysis revealed that naringin effectively suppressed NF-κB activation by inhibiting the degradation of IκB-α and the translocation of p65. Naringin also attenuated MAPK activation by inhibiting the phosphorylation of ERK1/2, JNK and p38 MAPK. Taken together, these demonstrate that naringin reduces IL-8, MCP-1 and MIP-1α secretion and mRNA expression, possibly by blocking the activation of the NF-κB and MAPK signaling pathways in LPS-induced RAW 264.7 macrophages.

View Figures

View References

1	Ware LB and Matthay MA: The acute respiratory distress syndrome. New Engl J Med. 342:1334–1349. 2000. View Article : Google Scholar : PubMed/NCBI
2	Lee WL and Downey GP: Neutrophil activation and acute lung injury. Curr Opin Crit Care. 7:1–7. 2001. View Article : Google Scholar : PubMed/NCBI
3	Gando S and Kameue T: Systemic inflammation and disseminated intravascular coagulation in early stage of ALI and ARDS: role of neutrophil and endothelial activation. Inflammation. 28:237–244. 2004. View Article : Google Scholar
4	Barnes PJ, Chung KF and Page CP: Inflammatory mediators of asthma: an update. Pharmacol Rev. 50:515–596. 1998.PubMed/NCBI
5	Rennard SI: Inflammation in COPD: a link to systemic comorbidities. Eur Respir Rev. 16:91–97. 2007. View Article : Google Scholar
6	Louis R, Lau LC, Bron AO, Roldaan AC, Radermecker M and Djukanović R: The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med. 161:9–16. 2000. View Article : Google Scholar : PubMed/NCBI
7	Stănescu D, Sanna A, Veriter C, Kostianev S, Calcagni PG, Fabbri LM and Maestrelli P: Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax. 51:267–271. 1996.PubMed/NCBI
8	Larsson K: Aspects on pathophysiological mechanisms in COPD. J Intern Med. 262:311–340. 2007. View Article : Google Scholar : PubMed/NCBI
9	Baggiolini M, Dewald B and Moser B: Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol. 55:97–179. 1994. View Article : Google Scholar : PubMed/NCBI
10	Reutershan J, Basit A, Galkina EV and Ley K: Sequential recruitment of neutrophils into lung and bronchoalveolar lavage fluid in LPS-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol. 289:L807–L815. 2005. View Article : Google Scholar : PubMed/NCBI
11	Horuk R: Molecular properties of the chemokine receptor family. Trends Pharmacol Sci. 15:159–165. 1994. View Article : Google Scholar : PubMed/NCBI
12	Barnes PJ: Alveolar macrophages as orchestrators of COPD. COPD. 1:59–70. 2004. View Article : Google Scholar : PubMed/NCBI
13	Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051–3064. 1992.PubMed/NCBI
14	Lemay S, Lebedeva TV and Singh AK: Inhibition of cytokine gene expression by sodium salicylate in a macrophage cell line through an NF-κB-independent mechanism. Clin Diagn Lab Immunol. 6:567–572. 1999.PubMed/NCBI
15	Raychaudhuri B, Abraham S, Bonfield TL, et al: Surfactant blocks lipopolysaccharide signaling by inhibiting both mitogen-activated protein and IκB kinases in human alveolar macrophages. Am J Respir Cell Mol Biol. 30:228–232. 2004.PubMed/NCBI
16	Kong XN, Yan HX, Chen L, et al: LPS-induced down-regulation of signal regulatory protein contributes to innate immune activation in macrophages. J Exp Med. 204:2719–2731. 2007. View Article : Google Scholar : PubMed/NCBI
17	Kim JH, Jeong JH, Jeon ST, et al: Decursin inhibits induction of inflammatory mediators by blocking nuclear factor-κB activation in macrophages. Mol Pharmacol. 69:1783–1790. 2006.PubMed/NCBI
18	Jagetia GC and Reddy TK: The grapefruit flavonone naringin protects against the radiation-induced genomic instability in the mice bone marrow: a micronucleus study. Mutat Res. 519:37–48. 2002. View Article : Google Scholar : PubMed/NCBI
19	Jain M and Parmar HS: Evaluation of antioxidative and anti-inflammatory potential of hesperidin and naringin on the rat air pouch model of inflammation. Inflamm Res. 60:483–491. 2011. View Article : Google Scholar : PubMed/NCBI
20	Golechha M, Chaudhry U, Bhatia J, Saluja D and Arya DS: Naringin protects against kainic acid-induced status epilepticus in rats: evidence for an antioxidant, anti-inflammatory and neuroprotective intervention. Biol Pharm Bull. 34:360–365. 2011. View Article : Google Scholar
21	Liu Y, Wu H, Nie YC, Chen JL, Su WW and Li PB: Naringin attenuates acute lung injury in LPS-treated mice by inhibiting NF-κB pathway. Int Immunopharmacol. 11:1606–1612. 2011.PubMed/NCBI
22	Kanno S, Shouji A, Tomizawa A, et al: Inhibitory effect of naringin on LPS-induced endotoxin shock in mice and nitric oxide production in RAW 264.7 macrophages. Life Sci. 78:673–681. 2006. View Article : Google Scholar : PubMed/NCBI
23	Lee CH, Jeong TS, Choi YK, et al: Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits. Biochem Biophys Res Commun. 284:681–688. 2001. View Article : Google Scholar : PubMed/NCBI
24	Liu L, Jia P, Yang YX and Yang L: Study on the effect of naringin on chemokine RANTES secretion in human keratinocyte and NF-κB signal pathway. China Pharm. 21:40–42. 2010.
25	Si-Si W, Liao L, Ling Z and Yun-Xia Y: Inhibition of TNF-α/IFN-γ induced RANTES expression in HaCaT cell by naringin. Pharm Biol. 49:810–814. 2011.
26	Kapitza SB, Michel BR, van Hoogevest P, Leigh ML and Imanidis G: Absorption of poorly water soluble drugs subject to apical efllux using phospholipids as solubilizers in the Caco-2 cell model. Eur J Pharm Biopharm. 66:146–158. 2007. View Article : Google Scholar : PubMed/NCBI
27	Amenomori M, Mukae H, Ishimatsu Y, et al: Differential effects of human neutrophil peptide-1 on growth factor and interleukin-8 production by human lung fibroblasts and epithelial cells. Exp Lung Res. 36:411–419. 2010. View Article : Google Scholar : PubMed/NCBI
28	Im J, Kang SS, Yang JS, Yun CH, Yang Y and Han SH: 3-Amino-1, 4-dimethyl-5H-pyrido [4, 3-b] indole (Trp-P-1) attenuates LPS-induced IL-8 expression by decreasing mRNA stability in THP-1 cells. Toxicol Lett. 177:108–115. 2008.
29	Melgarejo E, Medina MA, Sánchez-Jiménez F and Urdiales JL: Monocyte chemoattractant protein-1: A key mediator in inflammatory processes. Int J Biochem Cell Biol. 41:998–1001. 2009. View Article : Google Scholar : PubMed/NCBI
30	O’;Grady NP, Tropea M, Preas HL II, Reda D, Vandivier RW, Banks SM and Suffredini AF: Detection of macrophage inflammatory protein (MIP)-1alpha and MIP-1beta during experimental endotoxemia and human sepsis. J Infect Dis. 179:136–141. 1999.PubMed/NCBI
31	Luster AD: Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med. 338:436–445. 1998. View Article : Google Scholar : PubMed/NCBI
32	Beutler B and Rietschel ET: Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol. 3:169–176. 2003. View Article : Google Scholar : PubMed/NCBI
33	Kobayashi Y: The role of chemokines in neutrophil biology. Front Biosci. 13:2400–2407. 2008. View Article : Google Scholar : PubMed/NCBI
34	Gordon SB and Read RC: Macrophage defences against respiratory tract infections. The immunology of childhood respiratory infections. Br Med Bull. 61:45–61. 2002. View Article : Google Scholar : PubMed/NCBI
35	Murugan V and Peck MJ: Signal transduction pathways linking the activation of alveolar macrophages with the recruitment of neutrophils to lungs in chronic obstructive pulmonary disease. Exp Lung Res. 35:439–485. 2009. View Article : Google Scholar
36	Boven LA, Montagne L, Nottet HS and De Groot CJ: Macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions. Clin Exp Immunol. 122:257–263. 2000. View Article : Google Scholar
37	Ocaña MG, Asensi V, Montes AH, Meana A, Celada A and Valle-Garay E: Autoregulation mechanism of human neutrophil apoptosis during bacterial infection. Mol Immunol. 45:2087–2096. 2008.PubMed/NCBI
38	Abraham E: Neutrophils and acute lung injury. Crit Care Med. 31:S195–S199. 2003. View Article : Google Scholar : PubMed/NCBI
39	Vinten-Johansen J: Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res. 61:481–497. 2004. View Article : Google Scholar : PubMed/NCBI
40	Gerszten RE, Garcia-Zepeda EA, Lim YC, et al: MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature. 398:718–723. 1999. View Article : Google Scholar : PubMed/NCBI
41	Yeh SL, Wang HM, Chen PY and Wu TC: Interactions of beta-carotene and flavonoids on the secretion of pro-inflammatory mediators in an in vitro system. Chem Biol Interact. 179:386–393. 2009. View Article : Google Scholar : PubMed/NCBI
42	Yoshimura T, Yuhki N, Moore SK, Appella E, Lerman MI and Leonard EJ: Human monocyte chemoattractant protein-1 (MCP-1): full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett. 244:487–493. 1989. View Article : Google Scholar
43	Furie MB and Randolph GJ: Chemokines and tissue injury. Am J Pathol. 146:1287–1301. 1995.PubMed/NCBI
44	Kumar SN and Boss JM: Site A of the MCP-1 distal regulatory region functions as a transcriptional modulator through the transcription factor NF1. Mol Immunol. 37:623–632. 2000. View Article : Google Scholar : PubMed/NCBI
45	Car BD, Meloni F, Luisetti M, Semenzato G, Gialdroni-Grassi G and Walz A: Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med. 149:655–659. 1994. View Article : Google Scholar : PubMed/NCBI
46	Sherry B, Tekamp-Olson P, Gallegos C, et al: Resolution of the two components of macrophage inflammatory protein 1, and cloning and characterization of one of those components, macrophage inflammatory protein 1 beta. J Exp Med. 168:2251–2259. 1988. View Article : Google Scholar : PubMed/NCBI
47	Maurer M and von Stebut E: Macrophage inflammatory protein-1. Int J Biochem Cell Biol. 36:1882–1886. 2004. View Article : Google Scholar
48	Hasegawa M, Sato S and Takehara K: Augmented production of chemokines (MCP-1, MIP-1α and MIP-1β) in patients with systemic sclerosis: MCP-1 and MIP-1α may be involved in the development of pulmonary fibrosis. Clin Exp Immunol. 117:159–165. 1999.
49	Standiford TJ, Rolfe MW, Kunkel SL, et al: Macrophage inflammatory protein-1 alpha expression in interstitial lung disease. J Immunol. 151:2852–2863. 1993.PubMed/NCBI
50	Herlaar E and Brown Z: p38 MAPK signaling cascades in inflammatory disease. Mol Med Today. 5:439–447. 1999. View Article : Google Scholar : PubMed/NCBI
51	Cario E, Rosenberg IM, Brandwein SL, Beck PL, Reinecker HC and Podolsky DK: Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol. 164:966–972. 2000. View Article : Google Scholar : PubMed/NCBI
52	Giuliani C, Napolitano G, Bucci I, Montani V and Monaco F: NF-κB transcription factor: role in the pathogenesis of inflammatory, autoimmune, and neoplastic diseases and therapy implications. Clin Ter. 152:249–253. 2001.(In Italian).
53	Kim SW, Kim CE and Kim MH: Flavonoids inhibit high glucose-induced up-regulation of ICAM-1 via the p38 MAPK pathway in human vein endothelial cells. Biochem Biophys Res Commun. 415:602–607. 2011. View Article : Google Scholar : PubMed/NCBI
54	Bulzomi P, Bolli A, Galluzzo P, Leone S, Acconcia F and Marino M: Naringenin and 17 beta-estradiol coadministration prevents hormone-induced human cancer cell growth. IUBMB Life. 62:51–60. 2010.PubMed/NCBI
55	Bodet C, La VD, Epifano F and Grenier D: Naringenin has anti-inflammatory properties in macrophage and ex vivo human whole-blood models. J Periodont Res. 43:400–407. 2008. View Article : Google Scholar : PubMed/NCBI
56	Pu P, Gao DM, Mohamed S, et al: Naringin ameliorates metabolic syndrome by activating AMP-activated protein kinase in mice fed a high-fat diet. Arch Biochem Biophys. 518:61–70. 2012. View Article : Google Scholar : PubMed/NCBI
57	Carlsen H, Alexander G, Austenaa L, Ebihara K and Blomhoff R: Molecular cloning of the transcription factor NF-κB, a primary regulator of stress response. Mutat Res. 551:199–211. 2004.
58	Roman-Blas JA and Jimenez SA: NF-κB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage. 14:839–848. 2006.
59	Baeuerle PA and Baltimore D: NF-κB: ten years after. Cell. 87:13–20. 1996.
60	Dallot E, Méhats C, Oger S, Leroy MJ and Breuiller-Fouché M: A role for PKCzeta in the LPS-induced translocation NF-κB p65 subunit in cultured myometrial cells. Biochimie. 87:513–521. 2005.
61	Hämäläinen M, Nieminen R, Vuorela P, Heinonen M and Moilanen E: Anti-inflammatory effect of flavonoids: Genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-κB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-κB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm. 2007:456732007.PubMed/NCBI
62	Tsai SH, Lin-Shiau SY and Lin JK: Suppression of nitric oxide synthase and the down-regulation of the activation of NFκB in macrophages by resveratrol. Br J Pharmacol. 126:673–680. 1999.